CD38 and cancer: In contrast, a higher percentage of memory CD4+/ CD4+ T cells (P < .001), CD8+ HLA‐DR/ CD8+ T cells (P < .001), CD8+ CD38+/ CD8+ T cells (P < .001), and the CD4+/ CD8+ ratio (P < .001) were observed in cancer patients compared to healthy controls.